| Title |
Effects of cilostazol on cognition and regional cerebral blood flow in patients with Alzheimer's disease and cerebrovascular disease: A pilot study
|
|---|---|
| Published in |
Geriatrics & Gerontology International, June 2012
|
| DOI | 10.1111/j.1447-0594.2012.00866.x |
| Pubmed ID | |
| Authors |
Hirofumi Sakurai, Haruo Hanyu, Tomohiko Sato, Kazumasa Kume, Kentaro Hirao, Hidekazu Kanetaka, Toshihiko Iwamoto |
| Abstract |
It remains unknown whether antiplatelet agents have a preventive effect on cognitive decline in patients with Alzheimer's disease (AD). We investigated the effects of cilostazol, an antiplatelet agent and cyclic adenosine monophosphate phosphodiesterase 3 inhibitor, on cognition and regional cerebral blood flow (rCBF) in elderly patients with AD and cerebrovascular disease (CVD). |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1 | 1% |
| United Kingdom | 1 | 1% |
| Spain | 1 | 1% |
| Canada | 1 | 1% |
| Unknown | 91 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 18 | 19% |
| Student > Ph. D. Student | 15 | 16% |
| Student > Doctoral Student | 8 | 8% |
| Student > Bachelor | 8 | 8% |
| Other | 7 | 7% |
| Other | 18 | 19% |
| Unknown | 21 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 24 | 25% |
| Biochemistry, Genetics and Molecular Biology | 9 | 9% |
| Psychology | 8 | 8% |
| Neuroscience | 7 | 7% |
| Nursing and Health Professions | 5 | 5% |
| Other | 15 | 16% |
| Unknown | 27 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 June 2021.
All research outputs
#5,240,151
of 25,373,627 outputs
Outputs from Geriatrics & Gerontology International
#320
of 1,362 outputs
Outputs of similar age
#34,372
of 180,579 outputs
Outputs of similar age from Geriatrics & Gerontology International
#4
of 24 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,362 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.9. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 180,579 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.